GENOMA LAB INTERNATIONAL SAB DE CV ORDIN (OTCMKTS:GNMLF) had an increase of its short interest by 22.35%. FINRA issued short interest of GNMLF’s total 3.14M shares. The 2.57M previous shares are up with 22.35%.

At traded at $0.565 lastly.Since April 16, 2018 it’s 0.00% down thus . GNMLF underperformed the S&P500 by 4.37%.

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in research, manufacture, and marketing of pharmaceutical products and dermo cosmetics in Mexico.The firm is valued at $756.97 million.